Alan A. Azambuja

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 141 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Differential ectonucleotidase expression in human bladder cancer cell lines

Joséli Stella, Luci Bavaresco, Elizandra Braganhol et al. · Urologic Oncology Seminars and Original Investigations · 2009 · 80 citations

Medicine, Molecular Biology, Oncology +6

Association between bisphosphonates and jaw osteonecrosis: A study in Wistar rats

Marcia P. Maahs, Alan A. Azambuja, Maria M. Campos et al. · Head & Neck · 2010 · 79 citations · Full text

Dentistry, Oral Biology, Oral Pathology +13